Prevalence of epiphora in women with early breast cancer receiving adjuvant docetaxel-based chemotherapy

A study to assess the incidence of tearing as a consequence of docetaxel chemotherapy in women with early breast cancer

Status

Completed

Phases

Unknown

Study type

Observational

Source

ANZCTR

Registry ID

ACTRN12608000111370

Enrollment

Registered

2008-02-28

Start date

2007-11-30

Completion date

2010-06-01

Last updated

2021-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This study will monitor whether you develop tearing and if so, how frequent and severe this complaint is. It will involve assessment of theeyes before start chemotherapy, during and at the end of treatment.

Interventions

To measure the incidence of tearing by symptom review. clinical examination and Computerised tomography Dacrocystogram from baseline to 3 months following completion of chemotherapy

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Healthy volunteers

Inclusion criteria

Women with early breast cancer receiving docetaxel-based chemotherapy

Exclusion criteria

Tearing present prior to commencement of chemotherapy

Outcome results